Genetic characteristics and long-term follow-up of 11 patients with congenital hyperinsulinism followed in a single center

Abstract Background: Congenital hyperinsulinism (CHI) is a rare disease with an estimated incidence of 1:40,000 live births. Here, we characterize 11 patients treated at Munich Children’s Hospital Schwabing. Methods: We analyzed data on birth, treatment and laboratory results including genetic testing and evaluated the long-term course with a follow-up visit. Results: All patients had severe, diazoxide-(DZX)-resistant hypoglycemia, beginning immediately after birth. Two patients were treated by medical therapy, eight underwent subtotal pancreatectomy and one had a partial resection. Both patients who had medical therapy still suffer from occasional hypoglycemia. Six patients with subtotal pancreatectomy were affected by mild hypoglycemia. Seventy-five percent of patients who had surgical treatment developed diabetes mellitus (DM) at a median age of 10.5 (8–13) years. In 89% of patients with available genetic testing, mutations of the ABCC8 gene were detected. Conclusions: The majority of CHI-patients not responding to DZX underwent surgery. After subtotal pancreatectomy, patients typically developed diabetes around early puberty.

[1]  S. Ellard,et al.  Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation , 2015, Journal of pediatric endocrinology & metabolism : JPEM.

[2]  S. Ellard,et al.  Pancreatic Endocrine and Exocrine Function in Children following Near-Total Pancreatectomy for Diffuse Congenital Hyperinsulinism , 2014, PloS one.

[3]  Robert E. Brown,et al.  Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia. , 2014, The New England journal of medicine.

[4]  M. Zenker,et al.  Clinical and Genetic Evaluation of Patients with KATP Channel Mutations from the German Registry for Congenital Hyperinsulinism , 2014, Hormone Research in Paediatrics.

[5]  C. Stanley,et al.  Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. , 2013, The Journal of clinical endocrinology and metabolism.

[6]  F. Brunelle,et al.  Glucose Metabolism in 105 Children and Adolescents After Pancreatectomy for Congenital Hyperinsulinism , 2012, Diabetes Care.

[7]  W. Barthlen,et al.  Techniques in Pediatric Surgery: Congenital Hyperinsulinism , 2011, Hormone Research in Paediatrics.

[8]  W. Barthlen,et al.  Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L-dihydroxyphenylalanine in congenital hyperinsulinism. , 2011, Seminars in pediatric surgery.

[9]  S. Ellard,et al.  Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism , 2010, European journal of endocrinology.

[10]  Yves,et al.  ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism , 2010, Journal of Medical Genetics.

[11]  K. Hussain,et al.  Advances in the diagnosis and management of hyperinsulinemic hypoglycemia , 2009, Nature Clinical Practice Endocrinology &Metabolism.

[12]  S. Wiegand,et al.  Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy. , 2008, European journal of endocrinology.

[13]  G. Werther,et al.  Persistent Hyperinsulinaemic Hypoglycaemia of Infancy: 15 Years' Experience at the Royal Children's Hospital (RCH), Melbourne , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[14]  C. Stanley,et al.  Effects of hypoglycemia on developmental outcome in children with congenital hyperinsulinism. , 2005, Journal of pediatric nursing.

[15]  E. Mayatepek,et al.  Long-term follow-up of 114 patients with congenital hyperinsulinism. , 2003, European journal of endocrinology.

[16]  C. Sempoux,et al.  Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[17]  C. Junien,et al.  Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. , 1998, The Journal of clinical investigation.

[18]  C. Junien,et al.  Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. , 1997, The Journal of clinical investigation.

[19]  K. Perlman,et al.  Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate? , 1997, Journal of pediatric surgery.

[20]  J. Bryan,et al.  Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. , 1995, Science.

[21]  B. Glaser,et al.  Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. , 1995, The Journal of clinical endocrinology and metabolism.

[22]  H. Huopio,et al.  Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. , 2006, Diabetes.

[23]  M. Abduljabbar,et al.  Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI): Long-term Outcome Following 95% Pancreatectomy , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[24]  R. M. Shepherd,et al.  Hyperinsulinism in infancy: from basic science to clinical disease. , 2004, Physiological reviews.

[25]  C. Junien,et al.  Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases , 2001, European Journal of Pediatrics.